611
SSGJ-611-COPD-III-01
Phase 3 small_molecule active
Quick answer
611 for Pulmonary Disease, Chronic Obstructive (COPD) is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Pulmonary Disease, Chronic Obstructive (COPD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active